Jade Biosciences, Inc. Public Float
Jade Biosciences, Inc. (JBIO) had Public Float of $289.40 million as of 2025-06-30, per its 10-K filed 2026-03-06.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-06
- 2025-06-30: Entity Public Float $289.40M.
- 2024-06-30: Entity Public Float $23.00M.
- 2023-06-30: Entity Public Float $232.00M.
- 2022-06-30: Entity Public Float $157.30M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $289.40M 10-K · filed 2026-03-06 |
| 2024-06-30 | $23.00M 10-K · filed 2025-03-27 |
| 2023-06-30 | $232.00M 10-K · filed 2024-03-25 |
| 2022-06-30 | $157.30M 10-K · filed 2023-03-29 |
| 2021-07-02 | $185.09M 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |